Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 11, n. 2, p. 83–89, 2010. DOI: 10.7175/fe.v11i2.186. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/186. Acesso em: 28 dec. 2025.